Journals / European Journal of Rheumatology / 2018 / Cilt: 5 - Sayı: 4

Frequency of pulmonary hypertension in transthoracic echocardiography screening is not increased in Takayasu arteritis: Experience from a single center in Turkey

Pages
249–253
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, alow frequency of pulmonary arteritis in our series might have affected our results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Pulmonary hypertension (PH) may occur in Takayasu arteritis (TA), mostly due to pulmonaryarteritis, but also due to left heart disease and/or chronic thromboembolism (CTE).
📊
Key Findings & Data:Using transtho-racic echocardiography (TTE), we investigated the frequency of PH caused by pulmonary arteritis.Methods: This cross-sectional study included 70 patients with TA fulfilling the 1990 ACR criteria, 68healthy controls, and 67 patients with systemic sclerosis (SSc) fulfilling the 1980 ACR criteria repre-senting the disease control group.
💡
Conclusion & Impact:However, alow frequency of pulmonary arteritis in our series might have affected our results.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Pulmonary hypertension (PH) may occur in Takayasu arteritis (TA), mostly due to pulmonaryarteritis, but also due to left heart disease and/or chronic thromboembolism (CTE). Using transtho-racic echocardiography (TTE), we investigated the frequency of PH caused by pulmonary arteritis.Methods: This cross-sectional study included 70 patients with TA fulfilling the 1990 ACR criteria, 68healthy controls, and 67 patients with systemic sclerosis (SSc) fulfilling the 1980 ACR criteria repre-senting the disease control group. Patients with severe left heart disease or CTE were excluded. TheESC-ERS guideline definition was considered for diagnosis of PH.Results: The mean systolic pulmonary artery pressure (SPAP) values in TA, SSc, and healthy controlgroups were 20.93±6.06, 31.57±12.75, and 18.88±5.39 mmHg, respectively. While the SPAP valueswere similar between TA and healthy groups, the SPAP values in the SSc group were significantlyhigher than in other groups. Based on conventional and/or magnetic resonance angiography find-ings, pulmonary arteritis was present in 4 out of 70 TA patients; however, PH was not detected in anypatients with TA, including those with pulmonary arteritis.Conclusion: The TTE findings suggested that the frequency of PH was not increased in TA. However, alow frequency of pulmonary arteritis in our series might have affected our results.

🔖

Cite This Article

KAYIKÇIOĞLU, M., GÜNDÜZ, Ö. S., AKSU, K., AKKOÇ, N., KESER, G., EMMUNGİL, H., AKAR, S., İNAL, V., KALFA, M., MUSAYEV, O., YILMAZ, Z., ÖNEN, F. (2022). Frequency of pulmonary hypertension in transthoracic echocardiography screening is not increased in Takayasu arteritis: Experience from a single center in Turkey. European Journal of Rheumatology, Cilt: 5 - Sayı: 4, 249–253. https://ajindex.com/articles/511653

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu’s ar- teritis. Clinical study of 107 cases. Am Heart J 2007; 93: 94-103. [CrossRef] Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, et al. Takayasu’s arteritis in Tur- key-clinical and angiographic features of 248 patients. Clin Exp Rheumatol 2009; 27: 59-64.
  2. Sharma S, Kamalakar T, Rajani M, Talwar KK, Shrivastava S. The incidence and patterns of pulmonary artery involvement in Takayasu’s ar- teritis. Clin Radiol 1990; 42: 177-81. [CrossRef] Lupi E, Sanchez G, Horwitz S, Gutierrez E. Pul- monary artery involvement in Takayasu’s arteri- tis. Chest 1995; 67: 69-74. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hy- pertension: The Joint Task Force for the Diagno- sis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): En- dorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), Internation- al Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37: 67-119. [CrossRef] Peacock AJ, Murphy NF, Mcmurray JJV, Cabal- lero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007; 30: 104-9. [CrossRef] Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, et al. Early detection of pulmonary ar- terial hypertension in systemic sclerosis: A French nationwide prospective multicenter study. Arthri- tis Rheum 2005; 52: 3792-800. [CrossRef] Kayikçioğlu M, Kültürsay H. Seven years of ex- perience in patients with pulmonary arterial hypertension in Ege University Hospital: diag- nostic approach of a single center. Anadolu Kardiyol Derg 2008; 8: 279-85.
  3. Thenappan T, Shah SJ, Rich S, Gomberg-Mait- land M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 2007; 30: 1103-10. [CrossRef] Wang X, Dang A, Chen B, Lv N, Liu Q. Takayasu Arteritis-associated Pulmonary Hypertension. J Rheumatol 2015; 42: 495-503. [CrossRef] Lee GY, Jang SY, Ko SM, Kim EK, Lee SH, Han H, et al. Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease ac- tivity: Analysis of 204 Korean patients at a single center. Int J Cardiol 2012; 159: 14-20. [CrossRef] Sharma BK, Jain S, Radotra BD. An autopsy study of Takayasu arteritis in India. Int J Cardiol 1998; 1: 85-91. [CrossRef] Galiè N